Literature DB >> 15007537

Functional 5-HT receptors in human occipital artery.

Raphaela Verheggen1, Andreas Meier, Inga Werner, Andreas Wienekamp, Thomas Kruschat, Trond Brattelid, Finn Olav Levy, Alberto Kaumann.   

Abstract

5-HT receptors were studied in human occipital arteries, obtained from patients during neurosurgery. We detected mRNA for the following receptors (incidence): 5-HT(1B) (14/18), 5-HT(1D) (15/18), 5-HT(2A) (16/18), 5-HT(2B) (8/8), 5-HT(4(a)) (13/18), 5-HT(4(b)) (5/18), 5-HT(4(g)) (7/18), 5-HT(4(i)) (1/18), 5-HT(7(a/b)) (10/18) and 5-HT(7(d)) (12/18). 5-HT contracted and relaxed arterial rings at low (-logEC(50) M=7.0) and high (-logEC(50) M=4.2) concentrations, respectively. 5-HT-evoked contractions were antagonized partially by both 5-HT(1B)-selective SB224289 (200 nM) and 5-HT(2A)-selective ketanserin (1 microM) but not by 5-HT(1D)-selective BRL15572 (500 nM) or prazosin (1 microM). Sumatriptan caused contractions (-logEC(50) M=6.8, intrinsic activity with respect to 5-HT=0.3). Sumatriptan-evoked contractions were antagonized by SB224289 with high potency (pK(B)=9.4) but not by BRL15572. 5-HT-induced relaxations were resistant to blockade by 5-HT(1B)-selective SB224289 (1 microM), 5-HT(1D)-selective BRL15572, 5-HT(2B)-selective SB204741 (1 microM), 5-HT(4)-selective GR113808 (100 nM) and 5-HT(7)-selective SB269970 (1 microM), and a combination of SB204741 and SB269970, inconsistent with an involvement of 5-HT(1B), 5-HT(1D), 5-HT(2B), 5-HT(4) and 5-HT(7) receptors. Triton X-100 treatment of the arteries abolished acetylcholine-induced relaxations of rings precontracted by prostaglandin F(2alpha), but a reduction of the relaxant effects of 5-HT did not reach significance. Nitro-L-arginine (1 mM) reduced 5-HT-induced relaxations, suggesting a contribution of nitric oxide released from endothelial cells. Ketanserin (1 microM) prevented the relaxant effects of 5-HT. We conclude that 5-HT contracts human occipital artery through 5-HT(1B) receptors at low concentrations and through 5-HT(2A) receptors at high concentrations. Sumatriptan contracts mostly through 5-HT(1B) receptors. These results are consistent with the 5-HT(1B) and 5-HT(2A) mRNA data. 5-HT-induced relaxation is mediated, in part, through ketanserin-sensitive receptors, but 5-HT(1B), 5-HT(1D), 5-HT(2B), 5-HT(4) and 5-HT(7) receptors appear not to be involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007537     DOI: 10.1007/s00210-004-0878-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.

Authors:  J J Hagan; G W Price; P Jeffrey; N J Deeks; T Stean; D Piper; M I Smith; N Upton; A D Medhurst; D N Middlemiss; G J Riley; P J Lovell; S M Bromidge; D R Thomas
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.

Authors:  G W Price; M J Burton; L J Collin; M Duckworth; L Gaster; M Göthert; B J Jones; C Roberts; J M Watson; D N Middlemiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-09       Impact factor: 3.000

3.  The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.

Authors:  K A Krobert; T Bach; T Syversveen; A M Kvingedal; F O Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-06       Impact factor: 3.000

Review 4.  Human arterial constrictor serotonin receptors.

Authors:  A J Kaumann; A A Parsons; A M Brown
Journal:  Cardiovasc Res       Date:  1993-12       Impact factor: 10.787

Review 5.  Occipital neuralgias: clinical recognition of a complicated headache. A case series and literature review.

Authors:  W F Kuhn; S C Kuhn; H Gilberstadt
Journal:  J Orofac Pain       Date:  1997

6.  Blockade of human atrial 5-HT4 receptors by GR 113808.

Authors:  A J Kaumann
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).

Authors:  Trond Brattelid; Ane M Kvingedal; Kurt A Krobert; Kjetil W Andressen; Trond Bach; Marit E Hystad; Alberto J Kaumann; Finn Olav Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-30       Impact factor: 3.000

8.  Characterization of putative 5-ht7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein.

Authors:  E Leung; L K Walsh; M T Pulido-Rios; R M Eglen
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 9.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

10.  Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.

Authors:  D B Wainscott; V L Lucaites; J D Kursar; M Baez; D L Nelson
Journal:  J Pharmacol Exp Ther       Date:  1996-02       Impact factor: 4.030

View more
  7 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

Review 2.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

Authors:  Moti L Chapagain; Saguna Verma; Frederic Mercier; Richard Yanagihara; Vivek R Nerurkar
Journal:  Virology       Date:  2007-03-30       Impact factor: 3.616

4.  BIBN4096BS and CGRP(8-37) antagonize the relaxant effects of alpha-CGRP more than those of beta-CGRP in human extracranial arteries.

Authors:  Raphaela Verheggen; Kordian Wojtas; Martin Webel; Steffi Hoffmann; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-06-28       Impact factor: 3.000

5.  Vasopressin-induced constriction of the isolated rat occipital artery is segment dependent.

Authors:  Stephen P Chelko; Chad W Schmiedt; Tristan H Lewis; Stephen J Lewis; Tom P Robertson
Journal:  J Vasc Res       Date:  2013-10-29       Impact factor: 1.934

6.  Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation.

Authors:  Masanori Asada; Satoru Ebihara; Shinsuke Yamanda; Kaijun Niu; Tatsuma Okazaki; Ichiro Sora; Hiroyuki Arai
Journal:  Neoplasia       Date:  2009-04       Impact factor: 5.715

7.  Occipital Artery Function during the Development of 2-Kidney, 1-Clip Hypertension in Rats.

Authors:  Stephen P Chelko; Chad W Schmiedt; Tristan H Lewis; Tom P Robertson; Stephen J Lewis
Journal:  Int J Vasc Med       Date:  2014-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.